Drug-Induced Hepatotoxicity and Protection
Drug-Induced Hepatotoxicity and Protection is a research topic within Pharmacology. Science Explorer counts 36k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the mechanisms, risk factors, biomarkers, and management of drug-induced hepatotoxicity, with a specific emphasis on acetaminophen-induced liver injury. It covers topics such as oxidative stress, mitochondrial dysfunction, HLA genotype associations, idiosyncratic reactions, and the role of liver transplantation in severe cases.
- Hepatotoxicity
- Drug-Induced Liver Injury
- Acetaminophen
- Oxidative Stress
- Mitochondrial Dysfunction
- Antioxidants
- HLA Genotype
- Idiosyncratic Reactions
- Biomarkers
- Liver Transplantation
- Research works
- 36k fractional, since 1950
- In the world top 10%
- 3.6k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +8% the tick is no change
- Largest producer
China
27% of the 10 largest, 2022-now
Which countries lead Drug-Induced Hepatotoxicity and Protection research?
By volume, China and India publish the most (1.2k and 1.1k works in 2022-now).
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Drug-Induced Hepatotoxicity and Protection research?
By volume in 2022-now, Desh Bhagat Ayurvedic College and Hospital publishes the most Drug-Induced Hepatotoxicity and Protection research, followed by Cairo University and King Saud University.
By volume, 2022-now
- 1
Desh Bhagat Ayurvedic College and Hospital
India 36 works
- 2
Cairo University
Egypt 30 works
- 3
King Saud University
Saudi Arabia 29 works
- 4
University of Calicut
India 28 works
- 5
All India Institute of Medical Sciences
India 27 works
- 6
National Institute of Ayurveda
India 27 works
- 7
Mansoura University
Egypt 27 works
- 8
Government Ayurved College, Nanded
India 26 works
- 9
University of North Carolina at Chapel Hill
United States 26 works
- 10
Capital Medical University
China 25 works
Who are the leading researchers in Drug-Induced Hepatotoxicity and Protection?
The most-cited researchers publishing on Drug-Induced Hepatotoxicity and Protection include Zhong Lin Wang, Walter Churchill Willett and Mark J. Daly.
- 1
Zhong Lin Wang
United States 491k citations
- 2
Walter Churchill Willett
United States 411k citations
- 3
Mark J. Daly
United States 403k citations
- 4
Guido Kroemer
France 386k citations
- 5
Shizuo Akira
Japan 342k citations
- 6
Giuseppe Remuzzi
Italy 328k citations
- 7
Gregory Y.H. Lip
United Kingdom 311k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Drug-Induced Hepatotoxicity and Protection research done?
The largest centres of Drug-Induced Hepatotoxicity and Protection research in 2022-now are Beijing (China), Shanghai (China), New Delhi (India) and Cairo (Egypt). Among places with at least 20 works in it, it is an unusually large share of all research in Amloh, Malappuram and Nanded.
Largest cities, 2022-now
Where it is the local speciality
- AmlohIN · 37.1 works64×
- MalappuramIN · 29.8 works32×
- NandedIN · 28.0 works25×
- Port HarcourtNG · 32.1 works12×
Location quotient: how much more of its research is in Drug-Induced Hepatotoxicity and Protection than the world average.
Where is the best place to study Drug-Induced Hepatotoxicity and Protection?
Among universities, judged by research, Chengdu University of Traditional Chinese Medicine, King Saud University and Mansoura University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Drug-Induced Hepatotoxicity and Protection, country by countryIs Drug-Induced Hepatotoxicity and Protection research growing?
Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2022. The fastest-growing topics are Drug-Induced Hepatotoxicity and Protection.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Drug-Induced Hepatotoxicity and Protection as a percentage of every work published that year, 0.027% in 2024.
Fractional works of Drug-Induced Hepatotoxicity and Protection over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Drug-Induced Hepatotoxicity and Protection. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.